Literature DB >> 2021837

Thrombolytic therapy in the management of acute limb ischaemia.

J J Earnshaw1.   

Abstract

Acute limb ischaemia poses a threat to both the limb and life of a patient. Until recently, attempted revascularization by thromboembolectomy or vascular reconstruction held the best chance of limb salvage. Thrombolytic techniques afford an alternative method of management for this condition and are effective in selected patients. Low-dose intra-arterial streptokinase is the most established method of thrombolysis, although the recently developed tissue plasminogen activator offers a promising alternative. Intra-arterial thrombolysis is not an easy option, being labour intensive and requiring close co-operation between surgeon and radiologist. Thrombolytic and surgical techniques are not mutually exclusive but are best used to complement each other. Ideally patients with acute limb ischaemia should be managed by surgeons with knowledge of, and access to, optimal current surgical and non-surgical techniques.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021837     DOI: 10.1002/bjs.1800780304

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Intra-arterial thrombolysis should be the initial treatment of the acutely ischaemic lower limb.

Authors:  A E Giddings; W J Walker
Journal:  Ann R Coll Surg Engl       Date:  1992-07       Impact factor: 1.891

Review 2.  Lower limb intra-arterial thrombolysis.

Authors:  J Golledge; R B Galland
Journal:  Postgrad Med J       Date:  1995-03       Impact factor: 2.401

3.  Intraoperative use of thrombolytic agents.

Authors:  J J Earnshaw; J D Beard
Journal:  BMJ       Date:  1993-09-11

Review 4.  Thrombolysis in acute limb ischaemia.

Authors:  J J Earnshaw
Journal:  Ann R Coll Surg Engl       Date:  1994-07       Impact factor: 1.891

5.  "Bailout" Endovascular Treatment of Acute Aortic Occlusion.

Authors:  Konstantinos Tigkiropoulos; Kyriakos Stavridis; Ioannis Lazaridis; Nikolaos Saratzis
Journal:  Case Rep Vasc Med       Date:  2018-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.